210 related articles for article (PubMed ID: 21632457)
21. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
[TBL] [Abstract][Full Text] [Related]
22. The systematic relationship between melanomas diagnosed in situ and when invasive.
Lee JA
Melanoma Res; 2001 Oct; 11(5):523-9. PubMed ID: 11595891
[TBL] [Abstract][Full Text] [Related]
23. Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.
Weinstock MA; Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Pearson L; Piepkorn M; Barnhill RL; Elmore JG; Tosteson ANA
Br J Dermatol; 2017 Apr; 176(4):949-954. PubMed ID: 27639256
[TBL] [Abstract][Full Text] [Related]
24. Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma.
Braun MM; Tucker MA; Devesa SS; Hoover RN
Melanoma Res; 1994 Aug; 4(4):235-41. PubMed ID: 7950359
[TBL] [Abstract][Full Text] [Related]
25. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
26. Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method.
Adamson AS; Naik G; Jones MA; Bell KJ
BMJ Evid Based Med; 2024 May; 29(3):156-161. PubMed ID: 38242569
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
[TBL] [Abstract][Full Text] [Related]
28. Skin cancer. Melanoma and other specific nonmelanoma skin cancers.
Elder DE
Cancer; 1995 Jan; 75(1 Suppl):245-56. PubMed ID: 8000999
[TBL] [Abstract][Full Text] [Related]
29. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
30. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
Beroukhim K; Pourang A; Eisen DB
J Am Acad Dermatol; 2020 Mar; 82(3):683-689. PubMed ID: 31626886
[TBL] [Abstract][Full Text] [Related]
31. Presentation, Management, and Prognosis of Primary Gastrointestinal Melanoma: A Population-Based Study.
Kahl AR; Gao X; Chioreso C; Goffredo P; Hassan I; Charlton ME; Lin C
J Surg Res; 2021 Apr; 260():46-55. PubMed ID: 33316759
[TBL] [Abstract][Full Text] [Related]
32. Melanoma of the skin and laterality.
Dores GM; Huycke MM; Devesa SS
J Am Acad Dermatol; 2011 Jan; 64(1):193-5; author reply 195-6. PubMed ID: 21167412
[No Abstract] [Full Text] [Related]
33. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).
Mocellin S; Nitti D
Ann Oncol; 2013 Dec; 24(12):3040-4. PubMed ID: 24050954
[TBL] [Abstract][Full Text] [Related]
34. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
[TBL] [Abstract][Full Text] [Related]
35. Clinical diagnosis and therapy of cutaneous melanoma in situ.
Bartoli C; Bono A; Clemente C; Del Prato ID; Zurrida S; Cascinelli N
Cancer; 1996 Mar; 77(5):888-92. PubMed ID: 8608479
[TBL] [Abstract][Full Text] [Related]
36. Relationship of uveal and cutaneous malignant melanoma in persons with multiple primary tumors.
Shors AR; Iwamoto S; Doody DR; Weiss NS
Int J Cancer; 2002 Nov; 102(3):266-8. PubMed ID: 12397648
[TBL] [Abstract][Full Text] [Related]
37. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
38. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and Risk Factors in Patients with Multiple Primary Melanomas.
Nosrati A; Yu WY; McGuire J; Griffin A; de Souza JR; Singh R; Linos E; Chren MM; Grimes B; Jewell NP; Wei ML
J Invest Dermatol; 2019 Jan; 139(1):195-201. PubMed ID: 30031745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
